Rad50 Antibody (Rabbit mAb) [C10K20]

Catalog No.: F6295

    Application: Reactivity:
    • Lane 1: PANC-1, Lane 2: 293T, Lane 3: K562
    1/

    当該製品は品切れ状态で、メールアドレスをご教示いただければ、お客様に返信いたします。

    代表番号: 045-509-1970|電子メール:sales@selleck.co.jp

    キーポイント

    WB
    SDS-PAGE の分離ゲルの推奨濃度:5%

    使用情報

    Dilution
    1:1000
    1:200
    Application
    WB, IP
    Source
    Rabbit Monoclonal Antibody
    Reactivity
    Human
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW
    153 kDa
    ポジティブコントロール LS 180 cells; MIA PaCa-2 cells; SK-MEL-30 cells; K-562 cells; 293T cells; PANC-1 cells
    ネガティブコントロール

    プロトコール

    WB
    Experimental Protocol:
     
    Sample preparation
    1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/Nuclear Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature or lyse it by sonication on ice, then incubate on ice for 30 minutes.
    2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/Nuclear Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/Nuclear Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
    5. Remove a small volume of lysate to determine the protein concentration;
    6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
     
    Electrophoretic separation
    1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 5%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
    2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
     
    Transfer membrane
    1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
    2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
    3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
    4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
    Recommended conditions for wet transfer: 200 mA, 120 min.
    ( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
     
    Block
    1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
    2. Incubate the film in the blocking solution for 1 hour at room temperature;
    3. Wash the film with TBST for 3 times, 5 minutes each time.
     
    Antibody incubation
    1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
    2. Wash the film with TBST 3 times, 5 minutes each time;
    3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
    4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
     
    Antibody staining
    1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
    2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.

    Datasheet & SDS

    生物学的記述

    Specificity
    Rad50 Antibody (Rabbit mAb) [C10K20] detects endogenous levels of total Rad50 protein.
    タンパク質の局在
    染色体、細胞核、テロメア
    Uniprot ID
    Q92878
    Clone
    C10K20
    Synonym(s)
    DNA repair protein RAD50; hRAD50; NBSLD; RAD50; RAD50 double strand break repair protein; RAD50 homolog (S. cerevisiae); RAD50 homolog, double strand break repair protein; RAD50-2; RAD502
    Background
    RAD50 is an evolutionarily conserved structural maintenance of chromosomes (SMC)–related ATPase that functions as the central DNA tethering and signaling component of the MRE11–RAD50–NBS1 (MRN) complex, which orchestrates the detection, processing, and repair of DNA double‑strand breaks (DSBs), activation of ATM/ATR‑dependent checkpoint signaling, telomere maintenance, and meiotic recombination. The protein contains N‑ and C‑terminal Walker A and B ATPase motifs that fold into a globular ABC‑ATPase head, extended central coiled‑coil arms, and a C‑terminal Cys‑His‑His‑Cys zinc‑hook motif positioned at the apex of the coiled‑coils that coordinates a Zn²⁺ ion and mediates dimer–dimer interactions, allowing RAD50 dimers in the MRN complex to bridge distant DNA ends and form dynamic DNA loops important for end tethering and higher‑order chromatin architecture at sites of damage. ATP binding at the RAD50 head domains drives head‑to‑head engagement and converts MRN from an open conformation, in which MRE11 nuclease sites are solvent‑exposed, to a closed clamp in which broken DNA ends are juxtaposed and positioned into the MRE11 nuclease active site, providing ATP‑dependent control over end resection and conformational coupling between DNA tethering and nuclease activation. Within MRN, RAD50’s coiled‑coil and head domains bind DNA ends and hold them in close proximity, while MRE11 executes 3′–5′ exonuclease and endonuclease activities to initiate 5′‑end resection and generate 3′ single‑stranded DNA overhangs that become coated by RPA and later RAD51 during homologous recombination; NBS1 supplies phospho‑dependent interaction motifs that recruit ATM and other repair factors. MRN functions at the apex of the DNA damage response as a sensor and transducer: it recognizes DSBs, recruits and activates ATM through direct interaction, stimulates ATM autophosphorylation and monomerization, and supports ATR activation at resected ends, thereby triggering phosphorylation cascades that stabilize stalled replication forks, enforce intra‑S and G2/M checkpoints, and coordinate repair pathway choice between homologous recombination, classical non‑homologous end joining, and alternative end joining. RAD50 also contributes to telomere homeostasis by associating with chromosome ends, promoting t‑loop formation and end protection, and participating in the processing of telomeric DNA, while in meiosis MRN‑RAD50 facilitates programmed DSB processing required for homologous chromosome pairing and crossover formation. Germline biallelic hypomorphic mutations in RAD50 cause a Nijmegen breakage syndrome‑like disorder characterized by microcephaly, growth retardation, immunodeficiency, and radiosensitivity, with patient cells showing impaired DSB repair and defective checkpoint activation, highlighting RAD50’s essential role in genome stability. Somatic RAD50 alterations including missense, nonsense, and frameshift mutations are detected across multiple cancers, and MRN dysfunction associates with chromosomal instability and altered sensitivity to DNA‑damaging therapies.
    References

    技術サポート

    ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

    Handling Instructions

    他に質問がある場合は、お気軽にお問い合わせください。

    * 必須

    大学・企業名を記入してください
    名前を記入してください
    電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
    お問い合わせ内容をご入力ください